These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2885896

  • 1. Factors associated with decreased platelet MAO activity in chronic schizophrenics.
    Maj M, Arena F, Galderisi S, Starace F, Kemali D.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):79-86. PubMed ID: 2885896
    [Abstract] [Full Text] [Related]

  • 2. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
    Mészáros Z, Borcsiczky D, Máté M, Tarcali J, Tekes K, Magyar K.
    J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J, Thomas KM.
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [Abstract] [Full Text] [Related]

  • 9. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE, Wise CD, Bridge TP, Rosenblatt JE, Wagner RL, Morihisa J, Karson C, Potkin SG, Wyatt RJ.
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [Abstract] [Full Text] [Related]

  • 10. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
    Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ.
    Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M, Gruen R, Levitt M, Kane J.
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet monoamine oxidase in families of chronic schizophrenics.
    Berrettini WH, Benfield TC, Schmidt AO, Ladman RK, Vogel WH.
    Schizophr Bull; 1980 Oct; 6(2):235-7. PubMed ID: 7375856
    [Abstract] [Full Text] [Related]

  • 18. Human platelet MAO in drug-free and medicated schizophrenic patients.
    Friedhoff AJ, Miller JC, Weisenfreund J.
    Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
    [Abstract] [Full Text] [Related]

  • 19. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD, Kling A, Sutphin MS, Steinberg A, Eiduson S.
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [Abstract] [Full Text] [Related]

  • 20. Platelet monoamine oxidase activity in schizophrenia: relationship to family history of the illness and neuroleptic treatment.
    Maj M, Ariano MG, Pirozzi R, Salvati A, Kemali D.
    J Psychiatr Res; 1984 Jan; 18(2):131-7. PubMed ID: 6747911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.